调节内皮细胞内静态基因表达异质性的机制
Anna M Randi1, Daisy Jones1, Claire Peghaire2
1National Heart and Lung Institute, Imperial College London, London, UK.
Journal of thrombosis and haemostasis : JTH
|July 1, 2023
概括
内皮细胞表现出特定器官的血静性质,影响出血和凝血疾病. 转录调节驱动了这种内皮质异质性,影响了因子分布.
科学领域:
- 血管生物学 血管生物学
- 血液静止 血液静止 血液静止
- 细胞异质性 细胞异质性
背景情况:
- 静血系统依赖于凝血因子,血小板和内皮来控制凝血.
- 局部因素,特别是内皮质异质性,对于局部特异性出血和血栓性疾病至关重要.
- 内皮细胞在形态,功能和分子形状上表现出有机型差异.
研究的目的:
- 审查内皮细胞血静性概况的器官类型差异.
- 以维莱布兰德因子和血栓模块素为例,突出显示控制内皮异质性的转录机制.
- 讨论研究内皮质异质性的方法挑战和未来机会.
主要方法:
- 对转录和表观遗传学研究的审查.
- 对内皮细胞功能中的器官类型差异的分析.
- 专注于血液静止因子的转录调节.
主要成果:
- 内皮细胞在其静血功能中表现出显著的器官特异性变异.
- 转录调节是建立和维持内皮质多样性的关键机制.
- ·威尔布兰德因子和血栓模块蛋白表达是调控异质性的例子.
结论:
- 内皮质异质性在血静性疾病的特定部位性质中起着关键作用.
- 了解内皮细胞的转录控制对于理解血静至关重要.
- 需要进一步的研究来解决研究内皮质多样性的方法挑战.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Extrinsic and Intrinsic Pathways of Hemostasis
8.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.4K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Introduction to Hemostasis
8.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.4K


